| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0008 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |